I n 18-one-day-old anesthetized piglets. the effects of l-deamino-&D-arginine-vasopressin (DDAVP) with and without administration of dibutyryl adenosine 3':s'-monophosphate (DBcAMP) upon the urinary concentrating system were studied. Supramaximal doses of 20 pg DDAVP per kg body weight did not affect fractional water and fractional urea excretion, urinary flow rate, and relative urinary osmolarity. The same dose combined with DBcAMP (0.2 mg/kg body weight per min) changed these parameters significantly. This increase in the responsiveness of the urinary concentrating system to DDAVP by DBcAMP was paralleled by a significant increase in urinary and plasma cyclic adenosine 3':s'-monophosphate concentration and a tremendous increase in the Several in virro ( 15. 19. 2 I ) and in vivo ( l I ) studies have focused upon the parallelism between the development of the antidiuretic hormone (ADH)-sensitive cyclic adenosine 3'5'-monophosphate (CAMP) system and the development of the concentrating capacity during the neonatal period. It was found that the responsiveness of the medullary adenylate cyclase to ADH is decreased. but it increases with age (19). Furthermore. it has been suggested that the metabolism of CAMP in the neonatal renal medulla is altered (6. 14). so that the accumulation of CAMP in response to ADH is impaired. If such an intracellular "lack" of CAMP is a primary cause of the limitation of neonates to elevate urinary concentration. an increase of the medullary CAMP content by exogenous administration of CAMP should be followed by an increase in urinary concentration. However, administration of CAMP in vivo is difficult because it penetrates through cell membranes very slowly and is rapidly degraded by the phosphodiesterase (20). We therefore infused in the present study dibutyryl adenosine 3'3'-monophosphate (DBcAMP) to I-day-old newborn piglets. in which in an earlier study exogenous administration of ADH had been shown to be ineffective ( I I ) . I t has been proposed that this analog of cAMP is more rapidly transported across cell membranes and is less quickly hydrolyzed intra-and extracellularly by the phosphodiesterase than the naturally occurring CAMP (18). DBcAMP when injected in vivo in human infants. produced only minimal side effects (23).
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MATERIALS A N D METtIODS
Experiments were carried out on 19 piglets (strain: Deutsche Landrasse) weighing 1000 to I800 g. within the first 24 hr after their birth. The anesthesia of the animals was initiated with an IP injection of Inactin (60 to 100 mg/kg body weight b.w.): Byk Gulden. Konstant. West Germany) and sustained during the experiments by the I.V. injection of Nembutal (10 mg/kg b.w.: Boehringer Sohn. Ingelheim. West Germany). The piglets were placed on a heated operating table to maintain their temperature at 37°C. The trachea was cannulated. and a tube was inserted. and then the right external jugular vein was catheteri~ed for infusion of inulin and isotonic glucose solution. The right femoral artery was catheter~zed lor sampling blood and measuring arterial blood pressure. and the ureters were cannulated for sampling urine specimens. After completion of surgery. the piglets received an infusion of isotonic glucose solution at a rate of 30 ml/hr/kg b.w. and an infusion of inulin at a rate of 20 mg/min/kg b.w. The procedure induced a diuresis. When urine llow reached a steady state. inulin. urea, CAMP, and osmolarity were determined in plasma and urine for control. After this. the glucose infusion was stopped. but the inulin infusion was continued at the same rate. Then the different protocols were used.
In group I (six animals) after the control period. DBcAMP (~oehringer Mannheim. Mannheim West ~e r m -a n~) and I -deamino-8-I,-arginine-vasopressin (DDAVP) (Ferring. Malino. Sweden). (0.2 mg/kg b.w./min and 20 pg/kg b.w.. respectively) were infused over I hr. Blood and urine samples were obtained as described above. After I hr, the DBcAMP infusion was stopped. an additional infusion of DDAVP (20 pgikg b.w.) was administered over 2 hr. and blood and urine samples were repeated. In group 2 (five animals). initially only DDAVP (20 pg/kg b.w.) was infused over 2 hr, and blood and urine were sampled. Then a combined infusion of DDAVP (20 pg/kg b.w.) and DBcAMP (0.2 mg/kg b.w./min) over I hr was administered. The collection of urine and blood specimens was performed accordingly as in group I.
After the measurements. both kidneys were immediately removed and frozen in liquid nitrogen. Medullary CAMP content was determined in group 2, in a control group of sham operated animals. and in a group of animals which received only an infusion of DDAVP. The control group (three animals) received a glucose infusion. and the DDAVP group (four animals) received an additional infusion of DDAVP (20 pg/kg b.w.). After 2 hr. the kidneys were removed and f r o~e n in liquid nitrogen.
To assess whether DBcAMP can be degraded in the renal medulla, a further experimental series was performed. Slices of renal medulla of a I-day-old piglet were and pooled in ice-cold Tris-HCI buffer solution (pH 7.4; 10 mM). immediately homogenized in a Potter S homogenizer (Braun-Melsungen, Melsingen, West Germany), and then sonified for additional 30 sec with ultrasound (Branson instruments, Inc., Danbury, CT). The assay mixture (final volume, 1 ml) consisted of 0.12 pCi [''HIDBcAMP (Amersham. Buckinghamshire, England) and 20 pM unlabeled DBcAMP (Boehringer Mannheim) in 25 mM N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid (pH 7.4. 50 mM). Reaction was initiated with the addition of the renal medulla homogenate (124 pg/ml). After an incubation time of 30. 60. 90 min, reaction was terminated by boiling specimens for 5 min. After centrifugation, an aliquot of the clear supernatant was spotted on S~I -G / U V~M thin-layer plates (Machery-Nagel, Diiren, West Germany) together with carrier amounts of cAMP and DBcAMP and then developed with n-butano1:ethyl acetate:methano1:ammonium hydroxide (25%) (7:4:3:4, v/v) . The UV lightabsorbing areas of the chromatogram representing cAMP and DBcAMP were scraped off and counted for radioactivity in a Packard liquid scintillation spectrophotometer.
ANALYSES
lnulin was measured in urine and plasma by the antrone method (5): urea was measured by the Berthelot reaction (Asid Diagnostics. Unterschleissheim-Munich. West Germany). Osmolarities in urine and plasma were determined by free~ing point depression, and CAMP was determined after Gilman's method (7) using the test kit of Boehringer Mannheim. Urine was analyzed without further preparation. whereas the plasma samples were prepared as described by Hamet el al. (8) . To determine the medullary CAMP content. the frozen kidneys were placed on an aluminum plate and kept at a temperature of -10°C. The medulla was separated from the cortex and dissected into slices of 100 to 200 mg. Each slice was weighed. added to 2 ml of ice-cold I N perchloric acid. and homogenized in a Potter S homogenizer Table I . Effect of DDA VP and DDA VP plus DBcA M P on urin, (Braun-Melsungen, West Germany). ["HICAMP (for recovery) was added. The homogenate was centrifuged, and the supernatant was purified by columns of aluminum oxide (Sewa. Heidelberg. West Germany) and Dowex-SOW-X8. 200 to 400 mesh (Bio-Rad Laboratories. Richmond, CA) as described by Jacobs el al. (10) . The measurements were corrected for recovery (about 60%).
The assay itself is not sensitive to DBcAMP as has been previously demonstrated (13) . In addition. we found that no cAMP could be detected when DBcAMP was added to the assay.
CALCULATIONS
The results are expressed as the mean 2 standard deviation. Student's t test was used for significant differences between mean values. Table I shows that glomerular filtration rate as measured by inulin clearance was neither affected by the infusion of DDAVP nor DDAVP and DBcAMP. In both groups. the infusion of DDAVP and DBcAMP was followed by changes of fractional water. U/P,,.,,,. fractional urea excretion. (Fig. I ) and of absolute urea clearance and urine flow (Table I ). In group I (initially DDAVP and DBcAMP and then DDAVP alone) these effects attenuated when the infusion of DBcAMP was stopped. but the infusion of DDAVP repeated. In group 2 (initially DDAVP alone. then DDAVP and DBcAMP). no effects of DDAVP alone on the above parameters were observed.
RESULTS
The data of the medullary CAMP content is given in Figure 2 . In control animals which had received only glucose solution medullary CAMP content was 8.0 + 2.6/ 1 0 pmoles/g medulla.
These values did not differ significantly from the data of the animals which only had received DDAVP. The medullary CAMP content in this group was 6.4 + 2.5 x 10" pmoles/g medulla.
However. when DDAVP with DBcAMP was infused. the medullary CAMP content increased tremendously to 2.5 + 1.0 x 10' pmoles/g medulla. These effects were paralleled by changes of CAMP concentration in urine and blood (Table I ) ' Mean * S.D.
' P < 0.05. With these experiments. we studied the effects of DDAVP and DBcAMP on the renal concentrating system of newborn piglets by measuring their urinary llow rate. fractional water, fractional urea excretion. and U/P,,.,,,. The decrease of urinary flow rate and the increase of fractional water reabsorption and U/P,,.,,, in response to DDAVP and DBcAMP may be attributed to increasing effects of both drugs by changing the level of their endogenous CAMP production.
The main observation of this study is that the infusion of DDAVP does elicit an increase in urine osmolarity only when it is applied together with DBcAMP. This implies the following two conclusions. The restricted concentrating capacity of the renal medulla during the neonatal state results primarily from the reduced responsiveness of the medullary CAMP system to ADH and not. as it had been proposed in earlier papers, from the structural immaturity of the loop of Henle (2) or the reduced urea excretion (4) . Nevertheless. the relatively small increase in urinary osmolarity as compared to the adult state after the application of DDAVP and DBcAMP suggests further that other important components of the renal concentrating system are immature.
Secondly. because the increase in urinary concentration in response to the infusion of both DDAVP and DBcAMP is paralleled by a tremendous increase in medullary CAMP content. we suppose that it is the impaired accumulation of CAMP in the medullary tissue which restricts the concentrating capacity of the neonatal kidney. This view is also supported by findings in virro. In newborn rats (19. 21) . the responsiveness of the medullary adenylate cyclase to ADH was found to be reduced, but the activity of the medullary phosphodiesterase was found to be increased (6. 14) .
The increase of the medullary CAMP content in response to the infusion of DDAVP and DBcAMP remains unclear. Inasmuch as the infusion of DDAVP alone was ineffective. one may assume that this increase may be attributed to DBcAMP.
It is unlikely that the increase of the medullary CAMP content during the combined infusion of both drugs results from a degradation of the infused DBcAMP. This follows from our in virro results. When ["HIDBcAMP was incubated with a homogenate of the newborn renal medulla no ["HICAMP nor other metabolites were detected. This is similar to findings with adipose and bone tissue ( I . 9). but not to studies on the adult rat renal medulla (3) . cell cultures (12. 17) . and isolated bovine thyroid cells (22) . If one assumes that CAMP as measured in the renal medulla represents predominantely intracellular CAMP. it is also unlikely that CAMP. which might have been degraded from DBcAMP in other tissues. may considerably increase CAMP content. This assumption results from the low permeability of the cell membranes to CAMP and the fact that the concentration in the medullary tissue is several magnitudes higher than that in the plasma (24) . Therefore. it is more likely that the effect of DDAVP andUDBcAMP on the medullary CAMP content results predominantly from the stimulated synthesis of CAMP by the medullary adenylate cyclase in response to the applied DDAVP and the prevented destruction of this CAMP by DBcAMP inhibiting the activity of the phosphodiesterase. as it had been reported by others (3. 16) . 
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Thus. in conclusion. our data support the view that an altered metabolism of CAMP in the renal medullary tissue is a primary factor which restricts the concentrating capacity of the neonatal kidney.
